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'National Instba at Health and Nufrjtion, Shinjuku-ku, Tokyo, Japan. " ' -' __.-..... 2l%%& 6; Fundamental '&&a~ Sun tory, Ltd., Qsaka, Japan. ,3Na lions/ Delenss. Medical colldge, Saitama, Japan. Most of these studies, however,.have not investigated the influence of astaxanthin on LDL oxidation.
We therefore determined the in vitro susceptibility of LDL to oxidation following exposure to astaxanthin using our established method (9, 31, 32) of measuring conjugated dienes. Moreover, since the ex vivo effects of astaxanthincontaining supplements on LDL oxidation have not been examined in human subjects, we recruited volunteers to consume astaxanthin and then measured changes in LDL oxidizability.
Materials and Methods
Astaxanthin was extracted and purified by HPLC in large quantity from krill (husk) (18). Lutein, a-tocopherol and V-70 (2-2'-azobis(4-methoxy-2,4-dimethylvaferonitrile)) were from Wako Pure Chemicals, Osaka, Japan. Other reagents and solvents were of analytical grade and used without purification.
In vitro study
After overnight fasting, blood was collected in an EDTA-containing (1 g/L) tube from a normolipidemic healthy male volunteer. Plasma (1.1 ml) was adjusted to a 1 density of 1.21 kg/l and then layered under 2.8 ml saline 1 [ solution (d=1.006 kg/l) containing 0.1% EDTA in 3.9 ml quick seal tubes. The tubes were centrifuged at 417,000 x g for 40 min at 4'C (TLA 100.4 rotor) in a Beck-E man Optima TL ultracentrifuge.
The concentration of protein in the isolated LDL was determined using a ) R Ex viva study Twenty-four healthy volunteers (aged 28.257.8 y) consumed 1.8 (n = 5), 3.6 (n = 5), 14.4 (n = 3) or 21.6 (n = 5) mg of astaxanthin-containing supplements per day for 14 days. Six subjects were examined as controls. All participants were asked to maintain their habitual diet and lifestyle, and to stop taking vitamin supplements 2 weeks before the study began. A dietary record was obtained for 3 days before the study, and during the experimental period, subjects were given dietary instructions for 14days.
Nutrient intake was calculated from a database of foods based on the composition of Japanese foods. (33) The study was approved by the ethical committee of National Institute of Health and Nutrition (Japan) and all subjects provided informed consent. Fasting venous blood samples were taken at the start and the end of the study.
The plasma was separated by centrifugation at 2,000 x g for 15 min at 4-C, and LDL was isolated using a single spin ultracentrifugation procedure (34). The concentration of protein in the isolated LDL was determined using a modified Micro BCA method.
Oxidation of LDL (70 pg/ml protein) was initiated by the addition of V-70 (2. 2'-azobis(4-methoxy-2.4-dimethylvaleronitrile)) solution (final concentration 200 PM/ml) at 37'C and monitored using a spectrophotometer (Beckman DU-650) to follow changes of conjugated dienes at 234 nm absorbance every 4 min for 5 h (31, 32).
The lag time -was determined as the intercepts with the extrapolations of the parts of the curve representing the lag and propagation phases.
The serum lipid (total cholesterol, triglyceride) levels were assayed using enzymatic methods (Kyowa Medex Co., Ltd., Tokyo, Japan).
VLDL-cholesterol and LDLcholesterol levels were estimated using the Friedewald equation (36). HDL-cholesterol level was determined by a precipitation method (Kyowa Medex CO., Ltd., Tokyo, Japan). Apoprotein (apo Al, All, 6. CII. CIII. E ) levels were measured by turbidometric immunoassay (Daiichi Pure Chemicals Co:, Ltd., Tokyo, Japan).
The concentrations of serum a-tocopherol and p-carotene concentration were measured by HPLC(36, 37 Tables 1,2 . junyaku Co., Ltd., Tokyo Japan).
The LDL lag time increased after consuming astaxanthin at doses of 1.8,3.6, 14.4 and 21.6 mg for 14 dayq (Fig. 3) ,
Results
In vitro study
To evaluate the antioxidant effects of astaxanthin on LDL oxidation, LDL was incubated with increasing concentrations of astaxanthin and submitted to oxidation with V-70.
As shown in Fig. 1 , astaxanthin produced a dose dependent prolongation of oxidation of LDL @l&45.4, 65.0 min). The oxidation lag time was also prolonged by lutein and a-tocopherol (116.2,71.0 min.) (Fig. 2) . although this was less effective than astaxanthin (241.2 min) but no difference in Oxidation of LDL between day 0 (lag time 59.9 k7.2 min) and day 14 (57.2 & 6.0 min) was observed in the control group.
The mean serum a-tocopherol and 'p-carotene concentrations, shown in Table  3 , did not change significantly. The serum ascorbic acid level significantly decreased from 1.22 to 1 .I 3 mg/day after astaxanthin consumption 21.6 mg/day for 14 days. Additionally no changes were seen for serum uric acid, albumin and bilirubin levels, which were also act as antioxidants in the human body (Table 3 ). l l . Total energy intake did not change significantly during the experimental period. (Table 4) , and the intake of vitamins A, E and C in both the control and experimental grouPs remained stable during the experimental period. The intake of polyunsaturated, monounsaturated, It is thought that p-carotene reacts directly with a lipid peroxyl radical through a free radical chain reaction, and becomes a carbon-center radical stabilized by the resonance (39). Whereas astaxanthin and p-carotene act at the beginning of the chain reaction, the step at which the radical is generated, ,'3-tocopherol inhibits lipid peroxidation by scavenging the intermediate peroxyl radicals, thereby arresting the chain reaction (40).
Terao (30) studied the effect on the oxidation of various carotenoids using AMVN (2, 2'-azobis(2,4-dimethylvaleronitrile)) as a radical initiator.
A free-radical chain reaction was generated with methyl linoleate and AMVN, and the generation of the hydroperoxide was examined. by the exposure to the free radical generator for 4 h was not significant in the astaxanthin supplemented chicks indicating the existence of peroxyl radical-trapping activity.
In our study. however, there was no relationship between dose and either plasma p-carotene or a-tocopherol levels, with all doses resulting in roughly similar plasma levels of both nutrients. However, a more detailed investigation will be needed to solve the mechanisms of these interactions.
Within the living body some antioxidants exist that prevent formation of free radicals.
Uric acid, albumin and bilirubin were reported to be efficient antioxidants in vitro (41,42).
Levels of these substances were not altered during this study. 
